Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A... by Riccardo Scotto, Antonio Riccardo Buonomo, Antonio Iuliano, Maria Foggia, Alessia Sardanelli, Riccardo Villari, Biagio Pinchera, Ivan Gentile, Federico II COVID-Team

Get full text

Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 by Biagio Pinchera, Nicola Schiano Moriello, Antonio Riccardo Buonomo, Isabella Di Filippo, Anastasia Tanzillo, Giorgio Buzzo, Riccardo Villari, Ivan Gentile, Federico II COVID Team

Get full text

Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study by Ivan Gentile, Riccardo Scotto, Nicola Schiano Moriello, Biagio Pinchera, Riccardo Villari, Emilia Trucillo, Luigi Ametrano, Ludovica Fusco, Giuseppe Castaldo, Antonio Riccardo Buonomo, Federico II COVID Team

Get full text

Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients by Pinchera Biagio, Carrano Rosa, Schiano Moriello Nicola, Salemi Fabrizio, Piccione Amerigo, Zumbo Giulia, Scotto Riccardo, Villari Riccardo, Romano Paolo, Spirito Lorenzo, Gentile Ivan, Federico II COVID Team

Get full text

Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge by Riccardo Scotto, Antonio Riccardo Buonomo, Giulia Zumbo, Antonio Di Fusco, Nunzia Esposito, Isabella Di Filippo, Mariano Nobile, Biagio Pinchera, Nicola Schiano Moriello, Riccardo Villari, Ivan Gentile, Federico II COVID Team

Get full text

Risk Factors for <i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study by Giulio Viceconte, Antonio Riccardo Buonomo, Alessia D’Agostino, Maria Foggia, Antonio Di Fusco, Biagio Pinchera, Riccardo Scotto, Carmine Iacovazzo, Luca Fanasca, Gaetana Messina, Francesco Cacciatore, Paola Salvatore, Ivan Gentile, on behalf of the Federico II COVID Team

Get full text

A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 by Riccardo Scotto, Amedeo Lanzardo, Antonio Riccardo Buonomo, Biagio Pinchera, Letizia Cattaneo, Alessia Sardanelli, Simona Mercinelli, Giulio Viceconte, Alessandro Perrella, Vincenzo Esposito, Alessio Vinicio Codella, Paolo Maggi, Emanuela Zappulo, Riccardo Villari, Maria Foggia, Ivan Gentile, Federico II COVID-Team

Get full text

Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study) by Ivan Gentile, Agnese Giaccone, Maria Michela Scirocco, Francesco Di Brizzi, Federica Cuccurullo, Maria Silvitelli, Luigi Ametrano, Francesco Antimo Alfè, Daria Pietroluongo, Irene Irace, Mariarosaria Chiariello, Noemi De Felice, Simone Severino, Giulio Viceconte, Nicola Schiano Moriello, Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Riccardo Scotto, Federico II COVID team

Get full text